Categories
Agriculture Business Practice Health Care Law & Regulation Politics & Society

Citizens take agriculture ministry to court over Monsanto weedkiller

The Beijing No. 3 Intermediate People’s Court has accepted a lawsuit against the Ministry of Agriculture by three Chinese citizens over a toxicology report from 27 years ago supporting the approval of Monsanto weedkiller Roundup, the key ingredient of which was recently found to be “probably carcinogenic to humans” by a World Health Organization group, […]

Categories
Business Practice Health Care Tech, Media & Telecom

Hospital group boycott hits Baidu shares as ad revenue threatened

Baidu (BIDU.NYSE) shares fell 2.4% to US$203.60 after China Business News reported that members of an association of private hospitals in China, Bloomberg reported. The company, which is cracking down on what it says is false healthcare information in advertisements posted through its site, rejected ad requests last year for over 7,800 hospitals affiliated with the […]

Categories
Health Care Law & Regulation

Pfizer ceases vaccine commercial operations in China as sole license not renewed

Pfizer Inc. (PFE.NYSE) wil cease vaccine commercial operations in China after the government did not renew its import license for the only vaccine the company sells there, Bloomberg reported, citing a statement from the company. While the vaccine, Prevenar, is the only one for pneumococcal disease approved in China for children under two, no data proves […]

Categories
Health Care Law & Regulation Tech, Media & Telecom

China drugmakers set to boom–if they can get through regulatory system

A new drug for a rare type of lymph-node cancer developed entirely by Shenzhen Chipscreen Biosciences reflects the growing potential for China to become a major producer of new medicines thanks to local labs, scientists and interested investors, The Wall Street Journal reported, citing industry analysts and forecasts. But despite improved intellectual property protection, cumbersome rules for […]

Categories
Business Practice Health Care Law & Regulation

P&G's Crest hit with RMB6mn fine in China for alleged false advertising

The Crest toothpaste division of Procter & Gamble (PG.NYSE) has been fined nearly US$1 million for false advertising as the Shanghai Administration for Industry & Commerce claimed its commercials had exaggerated the effects of some brands of toothpaste and used digital enhancement to make teeth appear whiter, Reuters reported. The RMB6.03 million fine is the largest […]